# Bristol-Myers Squibb quarterly revenue

entity: /record/bristol-myers-squibb.md  
predicate: quarterly_revenue  
page: /record/bristol-myers-squibb/quarterly_revenue  
as_of: 2026-11-10  
cite: AsOf. "Bristol-Myers Squibb quarterly revenue: 13,069,000,000 United States dollar", as of 2026-09-30. Claim clm_41E4C7C8DCE2, https://asof.is/claim/clm_41E4C7C8DCE2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.  

As of November 10, 2026, Bristol-Myers Squibb's quarterly revenue on the AsOf record is $13.07 billion, dated September 30, 2026, from a primary source (sec.gov).

56 claims on Bristol-Myers Squibb's quarterly revenue, 1 open and 55 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted.

## Current quarterly revenue

What the record asserts on 2026-11-10.

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 13,069,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_41E4C7C8DCE2](/claim/clm_41E4C7C8DCE2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm

## Every dated value

One claim per line, oldest first. Superseded claims stay visible.

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,203,000,000 United States dollar | valid 2008-06-30 to 2008-09-30 | conf 0.95 | superseded | superseded_by [clm_F7EF5D23F54F](/claim/clm_F7EF5D23F54F.md) | [clm_BF6999DA6A38](/claim/clm_BF6999DA6A38.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,254,000,000 United States dollar | valid 2008-09-30 to 2009-03-31 | conf 0.95 | superseded | superseded_by [clm_C2AB7EFEF874](/claim/clm_C2AB7EFEF874.md) | [clm_F7EF5D23F54F](/claim/clm_F7EF5D23F54F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,322,000,000 United States dollar | valid 2009-03-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_23AB41FFB556](/claim/clm_23AB41FFB556.md) | [clm_C2AB7EFEF874](/claim/clm_C2AB7EFEF874.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,384,000,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_80EE21A24A79](/claim/clm_80EE21A24A79.md) | [clm_23AB41FFB556](/claim/clm_23AB41FFB556.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,487,000,000 United States dollar | valid 2009-09-30 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_F86EF4975AB0](/claim/clm_F86EF4975AB0.md) | [clm_80EE21A24A79](/claim/clm_80EE21A24A79.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,807,000,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_7E9207656793](/claim/clm_7E9207656793.md) | [clm_F86EF4975AB0](/claim/clm_F86EF4975AB0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,768,000,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_953918B58D21](/claim/clm_953918B58D21.md) | [clm_7E9207656793](/claim/clm_7E9207656793.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,798,000,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_73076406AD2F](/claim/clm_73076406AD2F.md) | [clm_953918B58D21](/claim/clm_953918B58D21.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,011,000,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_E02B6AA5ECE7](/claim/clm_E02B6AA5ECE7.md) | [clm_73076406AD2F](/claim/clm_73076406AD2F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,434,000,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_814D2D7EDE03](/claim/clm_814D2D7EDE03.md) | [clm_E02B6AA5ECE7](/claim/clm_E02B6AA5ECE7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511200164/0001193125-11-200164-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,345,000,000 United States dollar | valid 2011-09-30 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_D79B75C428AC](/claim/clm_D79B75C428AC.md) | [clm_814D2D7EDE03](/claim/clm_814D2D7EDE03.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511283608/0001193125-11-283608-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,251,000,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_962B22363E26](/claim/clm_962B22363E26.md) | [clm_D79B75C428AC](/claim/clm_D79B75C428AC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,443,000,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_5F4D49DAD603](/claim/clm_5F4D49DAD603.md) | [clm_962B22363E26](/claim/clm_962B22363E26.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512313811/0001193125-12-313811-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 3,736,000,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_7AD34DF2085B](/claim/clm_7AD34DF2085B.md) | [clm_5F4D49DAD603](/claim/clm_5F4D49DAD603.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512432664/0001193125-12-432664-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 3,831,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_5071BA073AB1](/claim/clm_5071BA073AB1.md) | [clm_7AD34DF2085B](/claim/clm_7AD34DF2085B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513172698/0001193125-13-172698-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,048,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_B320413C225B](/claim/clm_B320413C225B.md) | [clm_5071BA073AB1](/claim/clm_5071BA073AB1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427213000005/0000014272-13-000005-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,065,000,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_FBA07B943AA7](/claim/clm_FBA07B943AA7.md) | [clm_B320413C225B](/claim/clm_B320413C225B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427213000029/0000014272-13-000029-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 3,811,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_C0146E275324](/claim/clm_C0146E275324.md) | [clm_FBA07B943AA7](/claim/clm_FBA07B943AA7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000175/0000014272-14-000175-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 3,889,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_B93057222A64](/claim/clm_B93057222A64.md) | [clm_C0146E275324](/claim/clm_C0146E275324.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000214/0000014272-14-000214-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 3,921,000,000 United States dollar | valid 2014-09-30 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_1DAC03642CAB](/claim/clm_1DAC03642CAB.md) | [clm_B93057222A64](/claim/clm_B93057222A64.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000257/0000014272-14-000257-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,041,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_AB1D876445CB](/claim/clm_AB1D876445CB.md) | [clm_1DAC03642CAB](/claim/clm_1DAC03642CAB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000178/0000014272-15-000178-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,163,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_F94A6EEA38D3](/claim/clm_F94A6EEA38D3.md) | [clm_AB1D876445CB](/claim/clm_AB1D876445CB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000212/0000014272-15-000212-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,069,000,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_76DE4FA9E643](/claim/clm_76DE4FA9E643.md) | [clm_F94A6EEA38D3](/claim/clm_F94A6EEA38D3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000235/0000014272-15-000235-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,391,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_1DD87B004226](/claim/clm_1DD87B004226.md) | [clm_76DE4FA9E643](/claim/clm_76DE4FA9E643.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000399/0000014272-16-000399-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,871,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_18781A133073](/claim/clm_18781A133073.md) | [clm_1DD87B004226](/claim/clm_1DD87B004226.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000461/0000014272-16-000461-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,922,000,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_5F8F7439821E](/claim/clm_5F8F7439821E.md) | [clm_18781A133073](/claim/clm_18781A133073.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000491/0000014272-16-000491-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,929,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_13C469851C8D](/claim/clm_13C469851C8D.md) | [clm_5F8F7439821E](/claim/clm_5F8F7439821E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000132/0000014272-17-000132-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,144,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_3FA32606AD67](/claim/clm_3FA32606AD67.md) | [clm_13C469851C8D](/claim/clm_13C469851C8D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000165/0000014272-17-000165-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,254,000,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_EA4AEE2CC782](/claim/clm_EA4AEE2CC782.md) | [clm_3FA32606AD67](/claim/clm_3FA32606AD67.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000195/0000014272-17-000195-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,193,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_1C9B88505F80](/claim/clm_1C9B88505F80.md) | [clm_EA4AEE2CC782](/claim/clm_EA4AEE2CC782.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,704,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_94497E05D84C](/claim/clm_94497E05D84C.md) | [clm_1C9B88505F80](/claim/clm_1C9B88505F80.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,691,000,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_72FA5EB78BF3](/claim/clm_72FA5EB78BF3.md) | [clm_94497E05D84C](/claim/clm_94497E05D84C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,920,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_A94D041424B3](/claim/clm_A94D041424B3.md) | [clm_72FA5EB78BF3](/claim/clm_72FA5EB78BF3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 6,273,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_F9A04C9D9D15](/claim/clm_F9A04C9D9D15.md) | [clm_A94D041424B3](/claim/clm_A94D041424B3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 6,007,000,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_9C633E980249](/claim/clm_9C633E980249.md) | [clm_F9A04C9D9D15](/claim/clm_F9A04C9D9D15.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 10,781,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_1480298B3F56](/claim/clm_1480298B3F56.md) | [clm_9C633E980249](/claim/clm_9C633E980249.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000168/0000014272-20-000168-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 10,129,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_DF8AB3989828](/claim/clm_DF8AB3989828.md) | [clm_1480298B3F56](/claim/clm_1480298B3F56.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000229/0000014272-20-000229-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 10,540,000,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_90167993F3AC](/claim/clm_90167993F3AC.md) | [clm_DF8AB3989828](/claim/clm_DF8AB3989828.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000279/0000014272-20-000279-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,073,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_AE7B1C2AA687](/claim/clm_AE7B1C2AA687.md) | [clm_90167993F3AC](/claim/clm_90167993F3AC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,703,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_3ECFD6AA2B23](/claim/clm_3ECFD6AA2B23.md) | [clm_AE7B1C2AA687](/claim/clm_AE7B1C2AA687.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,624,000,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_D79D783840A8](/claim/clm_D79D783840A8.md) | [clm_3ECFD6AA2B23](/claim/clm_3ECFD6AA2B23.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,648,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_D5D7ABA783AD](/claim/clm_D5D7ABA783AD.md) | [clm_D79D783840A8](/claim/clm_D79D783840A8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,887,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_9D4962A5216A](/claim/clm_9D4962A5216A.md) | [clm_D5D7ABA783AD](/claim/clm_D5D7ABA783AD.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,218,000,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_D93AB25093EB](/claim/clm_D93AB25093EB.md) | [clm_9D4962A5216A](/claim/clm_9D4962A5216A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,337,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_C21A07FB73A6](/claim/clm_C21A07FB73A6.md) | [clm_D93AB25093EB](/claim/clm_D93AB25093EB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,226,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_2D8B38C2D603](/claim/clm_2D8B38C2D603.md) | [clm_C21A07FB73A6](/claim/clm_C21A07FB73A6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 10,966,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_8679C4DC1004](/claim/clm_8679C4DC1004.md) | [clm_2D8B38C2D603](/claim/clm_2D8B38C2D603.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,865,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_0C0D23505909](/claim/clm_0C0D23505909.md) | [clm_8679C4DC1004](/claim/clm_8679C4DC1004.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 12,201,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_ED30B6615116](/claim/clm_ED30B6615116.md) | [clm_0C0D23505909](/claim/clm_0C0D23505909.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,892,000,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_C316438CD5B0](/claim/clm_C316438CD5B0.md) | [clm_ED30B6615116](/claim/clm_ED30B6615116.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,201,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_BC0F7635AE7E](/claim/clm_BC0F7635AE7E.md) | [clm_C316438CD5B0](/claim/clm_C316438CD5B0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 12,269,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_BB784B853512](/claim/clm_BB784B853512.md) | [clm_BC0F7635AE7E](/claim/clm_BC0F7635AE7E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 12,222,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_3BBDC1786FBC](/claim/clm_3BBDC1786FBC.md) | [clm_BB784B853512](/claim/clm_BB784B853512.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,489,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_9331256657C6](/claim/clm_9331256657C6.md) | [clm_3BBDC1786FBC](/claim/clm_3BBDC1786FBC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 12,973,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_41E4C7C8DCE2](/claim/clm_41E4C7C8DCE2.md) | [clm_9331256657C6](/claim/clm_9331256657C6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 13,069,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_41E4C7C8DCE2](/claim/clm_41E4C7C8DCE2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm

## What replaced what

- $5.2 billion (2008-06-30 to 2008-09-30, [clm_BF6999DA6A38](/claim/clm_BF6999DA6A38.md)) was replaced by $5.25 billion from 2008-09-30 ([clm_F7EF5D23F54F](/claim/clm_F7EF5D23F54F.md))
- $5.25 billion (2008-09-30 to 2009-03-31, [clm_F7EF5D23F54F](/claim/clm_F7EF5D23F54F.md)) was replaced by $4.32 billion from 2009-03-31 ([clm_C2AB7EFEF874](/claim/clm_C2AB7EFEF874.md))
- $4.32 billion (2009-03-31 to 2009-06-30, [clm_C2AB7EFEF874](/claim/clm_C2AB7EFEF874.md)) was replaced by $5.38 billion from 2009-06-30 ([clm_23AB41FFB556](/claim/clm_23AB41FFB556.md))
- $5.38 billion (2009-06-30 to 2009-09-30, [clm_23AB41FFB556](/claim/clm_23AB41FFB556.md)) was replaced by $5.49 billion from 2009-09-30 ([clm_80EE21A24A79](/claim/clm_80EE21A24A79.md))
- $5.49 billion (2009-09-30 to 2010-03-31, [clm_80EE21A24A79](/claim/clm_80EE21A24A79.md)) was replaced by $4.81 billion from 2010-03-31 ([clm_F86EF4975AB0](/claim/clm_F86EF4975AB0.md))
- $4.81 billion (2010-03-31 to 2010-06-30, [clm_F86EF4975AB0](/claim/clm_F86EF4975AB0.md)) was replaced by $4.77 billion from 2010-06-30 ([clm_7E9207656793](/claim/clm_7E9207656793.md))
- $4.77 billion (2010-06-30 to 2010-09-30, [clm_7E9207656793](/claim/clm_7E9207656793.md)) was replaced by $4.8 billion from 2010-09-30 ([clm_953918B58D21](/claim/clm_953918B58D21.md))
- $4.8 billion (2010-09-30 to 2011-03-31, [clm_953918B58D21](/claim/clm_953918B58D21.md)) was replaced by $5.01 billion from 2011-03-31 ([clm_73076406AD2F](/claim/clm_73076406AD2F.md))
- $5.01 billion (2011-03-31 to 2011-06-30, [clm_73076406AD2F](/claim/clm_73076406AD2F.md)) was replaced by $5.43 billion from 2011-06-30 ([clm_E02B6AA5ECE7](/claim/clm_E02B6AA5ECE7.md))
- $5.43 billion (2011-06-30 to 2011-09-30, [clm_E02B6AA5ECE7](/claim/clm_E02B6AA5ECE7.md)) was replaced by $5.35 billion from 2011-09-30 ([clm_814D2D7EDE03](/claim/clm_814D2D7EDE03.md))
- $5.35 billion (2011-09-30 to 2012-03-31, [clm_814D2D7EDE03](/claim/clm_814D2D7EDE03.md)) was replaced by $5.25 billion from 2012-03-31 ([clm_D79B75C428AC](/claim/clm_D79B75C428AC.md))
- $5.25 billion (2012-03-31 to 2012-06-30, [clm_D79B75C428AC](/claim/clm_D79B75C428AC.md)) was replaced by $4.44 billion from 2012-06-30 ([clm_962B22363E26](/claim/clm_962B22363E26.md))
- $4.44 billion (2012-06-30 to 2012-09-30, [clm_962B22363E26](/claim/clm_962B22363E26.md)) was replaced by $3.74 billion from 2012-09-30 ([clm_5F4D49DAD603](/claim/clm_5F4D49DAD603.md))
- $3.74 billion (2012-09-30 to 2013-03-31, [clm_5F4D49DAD603](/claim/clm_5F4D49DAD603.md)) was replaced by $3.83 billion from 2013-03-31 ([clm_7AD34DF2085B](/claim/clm_7AD34DF2085B.md))
- $3.83 billion (2013-03-31 to 2013-06-30, [clm_7AD34DF2085B](/claim/clm_7AD34DF2085B.md)) was replaced by $4.05 billion from 2013-06-30 ([clm_5071BA073AB1](/claim/clm_5071BA073AB1.md))
- $4.05 billion (2013-06-30 to 2013-09-30, [clm_5071BA073AB1](/claim/clm_5071BA073AB1.md)) was replaced by $4.07 billion from 2013-09-30 ([clm_B320413C225B](/claim/clm_B320413C225B.md))
- $4.07 billion (2013-09-30 to 2014-03-31, [clm_B320413C225B](/claim/clm_B320413C225B.md)) was replaced by $3.81 billion from 2014-03-31 ([clm_FBA07B943AA7](/claim/clm_FBA07B943AA7.md))
- $3.81 billion (2014-03-31 to 2014-06-30, [clm_FBA07B943AA7](/claim/clm_FBA07B943AA7.md)) was replaced by $3.89 billion from 2014-06-30 ([clm_C0146E275324](/claim/clm_C0146E275324.md))
- $3.89 billion (2014-06-30 to 2014-09-30, [clm_C0146E275324](/claim/clm_C0146E275324.md)) was replaced by $3.92 billion from 2014-09-30 ([clm_B93057222A64](/claim/clm_B93057222A64.md))
- $3.92 billion (2014-09-30 to 2015-03-31, [clm_B93057222A64](/claim/clm_B93057222A64.md)) was replaced by $4.04 billion from 2015-03-31 ([clm_1DAC03642CAB](/claim/clm_1DAC03642CAB.md))
- $4.04 billion (2015-03-31 to 2015-06-30, [clm_1DAC03642CAB](/claim/clm_1DAC03642CAB.md)) was replaced by $4.16 billion from 2015-06-30 ([clm_AB1D876445CB](/claim/clm_AB1D876445CB.md))
- $4.16 billion (2015-06-30 to 2015-09-30, [clm_AB1D876445CB](/claim/clm_AB1D876445CB.md)) was replaced by $4.07 billion from 2015-09-30 ([clm_F94A6EEA38D3](/claim/clm_F94A6EEA38D3.md))
- $4.07 billion (2015-09-30 to 2016-03-31, [clm_F94A6EEA38D3](/claim/clm_F94A6EEA38D3.md)) was replaced by $4.39 billion from 2016-03-31 ([clm_76DE4FA9E643](/claim/clm_76DE4FA9E643.md))
- $4.39 billion (2016-03-31 to 2016-06-30, [clm_76DE4FA9E643](/claim/clm_76DE4FA9E643.md)) was replaced by $4.87 billion from 2016-06-30 ([clm_1DD87B004226](/claim/clm_1DD87B004226.md))
- $4.87 billion (2016-06-30 to 2016-09-30, [clm_1DD87B004226](/claim/clm_1DD87B004226.md)) was replaced by $4.92 billion from 2016-09-30 ([clm_18781A133073](/claim/clm_18781A133073.md))
- $4.92 billion (2016-09-30 to 2017-03-31, [clm_18781A133073](/claim/clm_18781A133073.md)) was replaced by $4.93 billion from 2017-03-31 ([clm_5F8F7439821E](/claim/clm_5F8F7439821E.md))
- $4.93 billion (2017-03-31 to 2017-06-30, [clm_5F8F7439821E](/claim/clm_5F8F7439821E.md)) was replaced by $5.14 billion from 2017-06-30 ([clm_13C469851C8D](/claim/clm_13C469851C8D.md))
- $5.14 billion (2017-06-30 to 2017-09-30, [clm_13C469851C8D](/claim/clm_13C469851C8D.md)) was replaced by $5.25 billion from 2017-09-30 ([clm_3FA32606AD67](/claim/clm_3FA32606AD67.md))
- $5.25 billion (2017-09-30 to 2018-03-31, [clm_3FA32606AD67](/claim/clm_3FA32606AD67.md)) was replaced by $5.19 billion from 2018-03-31 ([clm_EA4AEE2CC782](/claim/clm_EA4AEE2CC782.md))
- $5.19 billion (2018-03-31 to 2018-06-30, [clm_EA4AEE2CC782](/claim/clm_EA4AEE2CC782.md)) was replaced by $5.7 billion from 2018-06-30 ([clm_1C9B88505F80](/claim/clm_1C9B88505F80.md))
- $5.7 billion (2018-06-30 to 2018-09-30, [clm_1C9B88505F80](/claim/clm_1C9B88505F80.md)) was replaced by $5.69 billion from 2018-09-30 ([clm_94497E05D84C](/claim/clm_94497E05D84C.md))
- $5.69 billion (2018-09-30 to 2019-03-31, [clm_94497E05D84C](/claim/clm_94497E05D84C.md)) was replaced by $5.92 billion from 2019-03-31 ([clm_72FA5EB78BF3](/claim/clm_72FA5EB78BF3.md))
- $5.92 billion (2019-03-31 to 2019-06-30, [clm_72FA5EB78BF3](/claim/clm_72FA5EB78BF3.md)) was replaced by $6.27 billion from 2019-06-30 ([clm_A94D041424B3](/claim/clm_A94D041424B3.md))
- $6.27 billion (2019-06-30 to 2019-09-30, [clm_A94D041424B3](/claim/clm_A94D041424B3.md)) was replaced by $6.01 billion from 2019-09-30 ([clm_F9A04C9D9D15](/claim/clm_F9A04C9D9D15.md))
- $6.01 billion (2019-09-30 to 2020-03-31, [clm_F9A04C9D9D15](/claim/clm_F9A04C9D9D15.md)) was replaced by $10.78 billion from 2020-03-31 ([clm_9C633E980249](/claim/clm_9C633E980249.md))
- $10.78 billion (2020-03-31 to 2020-06-30, [clm_9C633E980249](/claim/clm_9C633E980249.md)) was replaced by $10.13 billion from 2020-06-30 ([clm_1480298B3F56](/claim/clm_1480298B3F56.md))
- $10.13 billion (2020-06-30 to 2020-09-30, [clm_1480298B3F56](/claim/clm_1480298B3F56.md)) was replaced by $10.54 billion from 2020-09-30 ([clm_DF8AB3989828](/claim/clm_DF8AB3989828.md))
- $10.54 billion (2020-09-30 to 2021-03-31, [clm_DF8AB3989828](/claim/clm_DF8AB3989828.md)) was replaced by $11.07 billion from 2021-03-31 ([clm_90167993F3AC](/claim/clm_90167993F3AC.md))
- $11.07 billion (2021-03-31 to 2021-06-30, [clm_90167993F3AC](/claim/clm_90167993F3AC.md)) was replaced by $11.7 billion from 2021-06-30 ([clm_AE7B1C2AA687](/claim/clm_AE7B1C2AA687.md))
- $11.7 billion (2021-06-30 to 2021-09-30, [clm_AE7B1C2AA687](/claim/clm_AE7B1C2AA687.md)) was replaced by $11.62 billion from 2021-09-30 ([clm_3ECFD6AA2B23](/claim/clm_3ECFD6AA2B23.md))
- $11.62 billion (2021-09-30 to 2022-03-31, [clm_3ECFD6AA2B23](/claim/clm_3ECFD6AA2B23.md)) was replaced by $11.65 billion from 2022-03-31 ([clm_D79D783840A8](/claim/clm_D79D783840A8.md))
- $11.65 billion (2022-03-31 to 2022-06-30, [clm_D79D783840A8](/claim/clm_D79D783840A8.md)) was replaced by $11.89 billion from 2022-06-30 ([clm_D5D7ABA783AD](/claim/clm_D5D7ABA783AD.md))
- $11.89 billion (2022-06-30 to 2022-09-30, [clm_D5D7ABA783AD](/claim/clm_D5D7ABA783AD.md)) was replaced by $11.22 billion from 2022-09-30 ([clm_9D4962A5216A](/claim/clm_9D4962A5216A.md))
- $11.22 billion (2022-09-30 to 2023-03-31, [clm_9D4962A5216A](/claim/clm_9D4962A5216A.md)) was replaced by $11.34 billion from 2023-03-31 ([clm_D93AB25093EB](/claim/clm_D93AB25093EB.md))
- $11.34 billion (2023-03-31 to 2023-06-30, [clm_D93AB25093EB](/claim/clm_D93AB25093EB.md)) was replaced by $11.23 billion from 2023-06-30 ([clm_C21A07FB73A6](/claim/clm_C21A07FB73A6.md))
- $11.23 billion (2023-06-30 to 2023-09-30, [clm_C21A07FB73A6](/claim/clm_C21A07FB73A6.md)) was replaced by $10.97 billion from 2023-09-30 ([clm_2D8B38C2D603](/claim/clm_2D8B38C2D603.md))
- $10.97 billion (2023-09-30 to 2024-03-31, [clm_2D8B38C2D603](/claim/clm_2D8B38C2D603.md)) was replaced by $11.87 billion from 2024-03-31 ([clm_8679C4DC1004](/claim/clm_8679C4DC1004.md))
- $11.87 billion (2024-03-31 to 2024-06-30, [clm_8679C4DC1004](/claim/clm_8679C4DC1004.md)) was replaced by $12.2 billion from 2024-06-30 ([clm_0C0D23505909](/claim/clm_0C0D23505909.md))
- $12.2 billion (2024-06-30 to 2024-09-30, [clm_0C0D23505909](/claim/clm_0C0D23505909.md)) was replaced by $11.89 billion from 2024-09-30 ([clm_ED30B6615116](/claim/clm_ED30B6615116.md))
- $11.89 billion (2024-09-30 to 2025-03-31, [clm_ED30B6615116](/claim/clm_ED30B6615116.md)) was replaced by $11.2 billion from 2025-03-31 ([clm_C316438CD5B0](/claim/clm_C316438CD5B0.md))
- $11.2 billion (2025-03-31 to 2025-06-30, [clm_C316438CD5B0](/claim/clm_C316438CD5B0.md)) was replaced by $12.27 billion from 2025-06-30 ([clm_BC0F7635AE7E](/claim/clm_BC0F7635AE7E.md))
- $12.27 billion (2025-06-30 to 2025-09-30, [clm_BC0F7635AE7E](/claim/clm_BC0F7635AE7E.md)) was replaced by $12.22 billion from 2025-09-30 ([clm_BB784B853512](/claim/clm_BB784B853512.md))
- $12.22 billion (2025-09-30 to 2026-03-31, [clm_BB784B853512](/claim/clm_BB784B853512.md)) was replaced by $11.49 billion from 2026-03-31 ([clm_3BBDC1786FBC](/claim/clm_3BBDC1786FBC.md))
- $11.49 billion (2026-03-31 to 2026-06-30, [clm_3BBDC1786FBC](/claim/clm_3BBDC1786FBC.md)) was replaced by $12.97 billion from 2026-06-30 ([clm_9331256657C6](/claim/clm_9331256657C6.md))
- $12.97 billion (2026-06-30 to 2026-09-30, [clm_9331256657C6](/claim/clm_9331256657C6.md)) was replaced by $13.07 billion from 2026-09-30 ([clm_41E4C7C8DCE2](/claim/clm_41E4C7C8DCE2.md))

## Questions this record answers

### What is Bristol-Myers Squibb's current quarterly revenue?

$13.07 billion, dated September 30, 2026, from a primary source (sec.gov). The record asserts this claim as of November 10, 2026 (status valid, confidence 0.95).

### When did Bristol-Myers Squibb's quarterly revenue last change?

The latest value on the record is $13.07 billion, dated September 30, 2026; before it the record holds $12.97 billion, dated June 30, 2026 and closed on September 30, 2026.

### What was Bristol-Myers Squibb's quarterly revenue before $13.07 billion?

$12.97 billion, valid from June 30, 2026 to September 30, 2026 (status superseded), from a primary source (sec.gov).


## Read on

- This page: /record/bristol-myers-squibb/quarterly_revenue (markdown: /record/bristol-myers-squibb/quarterly_revenue.md)
- Entity twin: /record/bristol-myers-squibb.md · timeline: /timelines/bristol-myers-squibb.md
- Every company's quarterly revenue: /facts/quarterly_revenue.md

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.